Professional Documents
Culture Documents
Adolescents and Adherence To Antiretroviral Treatment
Adolescents and Adherence To Antiretroviral Treatment
ABSTRACT
Some factors that are related to adherence to ARV treatment among adolescents are gender, age, marital status, Education,
place of residence, family size and religion. Drug related factors that are related to adherence to ARV treatment among
adolescents include having all the drugs they are supposed to take, challenges faced with the drugs, Frequency of taking ARV
pills in a day, challenges faced when taking ARVs and accessibility to ARV drugs. Health related factors that are related to
adherence to ARV treatment among adolescents are getting routine education and counseling about adherence to ARVs, source
of information, had nearby health care facility to pick ARV drugs, distance between health facility and respondents’ home,
availability of ARV on appointment day, availability of health care workers for ARV services.
Keywords: ART, adolescents, adherence, HIV, AIDS, ARV
INTRODUCTION
Adolescence usually refers to the period between the ages of 13 and 19 and represents the transition from childhood to
adulthood. However, the physical and psychological changes that occur during puberty can begin as early as the teenage years
or between 9 and 12 years of age [1]. On the other hand, the World Health Organization defines adolescence as the age from
her 10 years to her 24 years [2]. In this study, adolescents were considered to be between the ages of 10 and 2. Treatment
adherence is one of the strongest predictors of virologic failure, development of drug resistance, disease progression, and
mortality [3]. Low adherence to combination antiretroviral therapy (CART) is common in both developing and developed
countries [4-8]. It is found in approximately 20% of HIV-infected patients in Africa and approximately 14% in the United States
[9]. By the end of 2014, approximately 37 million people were living with the human immunodeficiency virus (HIV)
worldwide, mostly from low- and middle-income countries. Fifteen million people living with HIV are receiving
antiretroviral (ARV) therapy [10-13], and the number of people with ART has doubled since 2010.Estimates of ART
adherence among adolescents living with HIV (ALHIV) in low- and middle-income countries (LMICs) vary widely [14-18].
Adherence among young people worldwide ranged from 16% to 99% [19]. Since 2014, a meta-analysis of adolescents and young
adults (ages 12–24) from 53 countries has shown an 84% adherence rate based on self-reported or viral load measurements in
both Africa and Asia. [20].
Page |
50